Anticipatory nausea and vomiting, as a side-effect of cancer chemotherapy, is a well-recognised phenomenon known to affect a substantial minority of patients. Although explicable using a conditioning model, it may have a complex aetiology with affective and cognitive elements as well as specific pha
โฆ LIBER โฆ
Anticipatory nausea and vomiting in the era of 5-HT3antiemetics
โ Scribed by G. R. Morrow; Joseph A. Roscoe; Jeffrey J. Kirshner; Harry E. Hynes; Richard J. Rosenbluth
- Publisher
- Springer-Verlag
- Year
- 1998
- Tongue
- English
- Weight
- 30 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Anticipatory nausea and vomiting: broade
โ
Maggie Watson
๐
Article
๐
1993
๐
Springer-Verlag
๐
English
โ 691 KB
5-HT3receptor antagonistsvstraditional a
โ
Peter S. Loewen; Carlo A. Marra; Peter J. Zed
๐
Article
๐
2000
๐
Springer-Verlag
๐
French
โ 131 KB
Progress in reducing anticipatory nausea
โ
G. R. Morrow; Joseph A. Roscoe; Harry E. Hynes; Patrick J. Flynn; H. Irving Pier
๐
Article
๐
1997
๐
Springer-Verlag
๐
English
โ 138 KB
Use of antiemetics in the management of
โ
Alexander Molassiotis; Sarah G. Brearley; Zoe Stamataki
๐
Article
๐
2010
๐
Springer-Verlag
๐
English
โ 123 KB
GR38032F, a 5HT3receptor antagonist, in
โ
Michel Marty; Jean P. Droz; Pierre Pouillart; Bernard Paule; Nils Brion; Jacques
๐
Article
๐
1989
๐
Springer
๐
English
โ 330 KB
A total of 28 patients receiving cancer chemotherapy with cisplatin-containing regimens (70-120 mg/ m 2) participated in an evaluation of the efficacy and safety of GR38032F for the prevention of acute nausea and vomiting. GR38032F, a 5HT3 receptor antagonist, was given 30 min prior to cisplatin as
Granisetron in the control of radiothera
โ
Petra Feyer; M. Heinrich Seegenschmiedt; Maria Steingraeber
๐
Article
๐
2005
๐
Springer-Verlag
๐
English
โ 157 KB